Benzinga · Mar 4, 2026
RB
NASDAQ · RBOT
Vicarious Surgical Inc.
Healthcare · Medical - Devices
$0.06
Up+$0.00 (+3.45%)
Updated Aug 15, 2026, 6:51 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.09M
- P/E ratio
- -0.27
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 11.29K
- Avg. volume
- 111.8K
Price performance
RBOT price history
1M range · 0 trading sessions · Daily adjusted prices
RBOT does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest RBOT news
The latest Smart Investors Daily articles mentioning RBOT.
Stock researchCompany · Overview
RBOT research
Overview
Company profile and research snapshot.
Company profile
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.75
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2025 | Piper Sandler | Neutral | — |
| Mar 18, 2025 | Piper Sandler | Neutral | — |
| Nov 13, 2024 | Piper Sandler | Neutral | — |
| Aug 13, 2024 | Piper Sandler | Neutral | — |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Yahoo · Jan 12, 2026
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
WALTHAM, Mass., January 12, 2026--Vicarious Surgical (NYSE: RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the successful completion of an in-vivo porcine lab conducted in December 2025, marking a meaningful step forward in the development of the company’s robotic system and reinforcing progress toward system design freeze targeted for the end of 2026.
Yahoo · Jan 6, 2026
Vicarious inks software partnership as it streamlines operations
Under the agreement, the engineering partner will be responsible for a significant portion of the software development for the Vicarious robotic system.
Yahoo · Dec 30, 2025
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
